5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multicenter sequential phase II study of flavopiridol plus oxaliplatin (Alvocidib) with or without 5-FU and leucovorin (LV) for patients (pts) with refractory germ cell tumors (GCT) including late relapse (LR)
    Meeting Abstract

    Feldman, D. R.; Stadler, W. M.; Appleman, L. J.; Quinn, D. I.; Costello, B. A.; Schwartz, G. K.; Reuter, V. E.; Woo, K.; Patil, S.; Fusco, A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Biomarker analysis from a phase III trial (GOLD) of dovitinib (Dov) versus sorafenib (Sor) in patients with metastatic renal cell carcinoma after one prior VEGF pathway-targeted therapy and one prior mTOR inhibitor therapy
    Meeting Abstract

    Escudier, B. J.; Porta, C.; Squires, M.; Szczylik, C.; Kollmannsberger, C. K.; Melichar, B.; Rha, S. Y.; Esteban, E.; Bjarnason, G. A.; Vogelzang, N. J.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Results of subset analyses on overall survival (OS) from study CA184-043: Ipilimumab (Ipi) versus placebo (Pbo) in post-docetaxel metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Drake, C. G.; Kwon, E. D.; Fizazi, K.; Bossi, A.; Van Den Eertwegh, A. J. M.; Logothetis, C.; Scher, H. I.; Beer, T. M.; McHenry, B.; Liu, D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Pelvic exenteration in patients with nonmetastatic, locally advanced castration-resistant prostate cancer
    Meeting Abstract

    Donahue, T. F.; Morris, M. J.; Hilton, W. M.; Scher, H. I.; Bochner, B. H.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Molecular characterization of circulating tumor cells (CTC) and CTC subpopulations in progressive metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Dittamore, R.; Louw, J.; Krupa, R.; Anand, A.; Danila, D. C.; Arslan, Z.; Bales, N.; Marrinucci, D.; Scher, H. I.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Correlation of PDL1 tumor expression and treatment outcomes in patients with renal cell carcinoma (RCC) receiving tyrosine kinase inhibitors: COMPARZ study analysis
    Meeting Abstract

    Choueiri, T. K.; Figueroa, D. J.; Liu, Y.; Gagnon, R. C.; Deen, K. C.; Carpenter, C.; Bartlett-Pandite, A. N.; De Souza, P.; Powles, T.; Motzer, R. J.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Branched evolution and intratumor heterogeneity of urothelial carcinoma of the bladder
    Meeting Abstract

    Cha, E. K.; Sfakianos, J. P.; Al-Ahmadie, H.; Scott, S. N.; Kim, P. H.; Iyer, G.; Bajorin, D. F.; Rosenberg, J. E.; Berger, M. F.; Bochner, B. H.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Multi-institutional quality care initiative (QCI) to improve the care of patients with invasive bladder cancer (BlCa)
    Meeting Abstract

    Bochner, B. H.; Feifer, A.; Sperling, D.; Mashni, J. W.; Bajorin, D. F.; Shah, J. B.; Kamat, A. M.; Steinberg, G. D.; Stadler, W. M.; Grubb, R. L.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Efficacy of single-agent pemetrexed in platinum refractory metastatic urothelial cancer (mUC)
    Meeting Abstract

    Benjamin, D. J.; Bambury, R. M.; Chaim, J.; Zabor, E. C.; Ostrovnaya, I.; Garcia-Grossman, I. R.; Iyer, G.; Bajorin, D. F.; Rosenberg, J. E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Somatic copy number abnormalities (SCNAs) and mutations in PI3K/AKT pathway and prognostic significance for overall survival (OS) in platinum-treated locally advanced or metastatic urothelial cancer (UC)
    Meeting Abstract

    Bellmunt, J.; Werner, L.; Riester, M.; Van Hummelen, P.; Rosenberg, J. E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save